AGMB
AgomAb Therapeutics NV - ADRs representing one common share. (AGMB)
$73
About AgomAb Therapeutics NV - ADRs representing one common share. (AGMB)
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases. Its mission is to develop disease-modifying therapeutics that aim to resolve fibrosis and restore organ function, enabling patients with these disorders to live fuller and healthier lives. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium.
Details
Daily high
$13.86
Daily low
$13.42
Price at open
$13.62
52 Week High
$17.82
52 Week Low
$8.75
Market cap
673.7M
Dividend yield
-
Volume
30,866
Avg. volume
98,549
P/E ratio
--
AgomAb Therapeutics NV - ADRs representing one common share. News
Details
Daily high
$13.86
Daily low
$13.42
Price at open
$13.62
52 Week High
$17.82
52 Week Low
$8.75
Market cap
673.7M
Dividend yield
-
Volume
30,866
Avg. volume
98,549
P/E ratio
--